Lorzadeh A, Ye G, Sharma S, Jadhav U
Nat Commun. 2025; 16(1):929.
PMID: 39843425
PMC: 11754732.
DOI: 10.1038/s41467-025-56187-0.
Zhang R, Chen Y, Feng Z, Cai B, Cheng Y, Du Y
Heliyon. 2024; 10(13):e33736.
PMID: 39040281
PMC: 11261862.
DOI: 10.1016/j.heliyon.2024.e33736.
Vilarinho T, Padua D, Pereira B, Mesquita P, Almeida R
Curr Oncol. 2024; 31(5):2769-2779.
PMID: 38785491
PMC: 11120023.
DOI: 10.3390/curroncol31050210.
Lorzadeh A, Ye G, Sharma S, Jadhav U
bioRxiv. 2024; .
PMID: 38405700
PMC: 10888781.
DOI: 10.1101/2024.02.11.579850.
Yang L, Tu L, Bisht S, Mao Y, Petkovich D, Thursby S
Nat Commun. 2024; 15(1):1384.
PMID: 38360902
PMC: 10869357.
DOI: 10.1038/s41467-024-45605-4.
Human regulates endoderm patterning at the primitive gut tube stage.
Nakamura T, Fujikura J, Ito R, Keidai Y, Inagaki N
PNAS Nexus. 2024; 3(1):pgae001.
PMID: 38239755
PMC: 10794167.
DOI: 10.1093/pnasnexus/pgae001.
Development of functional resident macrophages in human pluripotent stem cell-derived colonic organoids and human fetal colon.
Munera J, Kechele D, Bouffi C, Qu N, Jing R, Maity P
Cell Stem Cell. 2023; 30(11):1434-1451.e9.
PMID: 37922878
PMC: 10913028.
DOI: 10.1016/j.stem.2023.10.002.
PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells.
Maharati A, Moghbeli M
Cell Commun Signal. 2023; 21(1):201.
PMID: 37580737
PMC: 10424373.
DOI: 10.1186/s12964-023-01225-x.
Characterization of cell-fate decision landscapes by estimating transcription factor dynamics.
Jimenez S, Schreiber V, Mercier R, Gradwohl G, Molina N
Cell Rep Methods. 2023; 3(7):100512.
PMID: 37533652
PMC: 10391345.
DOI: 10.1016/j.crmeth.2023.100512.
A single-cell transcriptional timelapse of mouse embryonic development, from gastrula to pup.
Qiu C, Martin B, Welsh I, Daza R, Le T, Huang X
bioRxiv. 2023; .
PMID: 37066300
PMC: 10104014.
DOI: 10.1101/2023.04.05.535726.
The G Protein-Coupled Receptor, VPAC1, Mediates Vasoactive Intestinal Peptide-Dependent Functional Homeostasis of the Gut Microbiota.
Ericsson A, Bains M, McAdams Z, Daniels J, Busi S, Waschek J
Gastro Hep Adv. 2023; 1(2):253-264.
PMID: 36910129
PMC: 9997614.
DOI: 10.1016/j.gastha.2021.11.005.
A cellular senescence-related genes model allows for prognosis and treatment stratification of hepatocellular carcinoma: A bioinformatics analysis and experimental verification.
Li J, Tan R, Wu J, Guo W, Wang Y, You G
Front Genet. 2023; 13:1099148.
PMID: 36712870
PMC: 9877353.
DOI: 10.3389/fgene.2022.1099148.
Intestinal precursors avoid being misinduced to liver cells by activating Cdx-Wnt inhibition cascade.
Yang Y, Li Y, Fu J, Li Y, Li S, Ni R
Proc Natl Acad Sci U S A. 2022; 119(45):e2205110119.
PMID: 36396123
PMC: 9659337.
DOI: 10.1073/pnas.2205110119.
CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer.
Wang Y, Kou Y, Zhu R, Han B, Li C, Wang H
Dis Markers. 2022; 2022:9025668.
PMID: 36277982
PMC: 9582897.
DOI: 10.1155/2022/9025668.
Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer.
Mochizuki K, Kudo S, Kato K, Kudo K, Ogawa Y, Kouyama Y
PLoS One. 2022; 17(10):e0273566.
PMID: 36264865
PMC: 9584453.
DOI: 10.1371/journal.pone.0273566.
Predicting lymph node metastasis and recurrence in patients with early stage colorectal cancer.
Chen L, Yang F, Qi Z, Tai J
Front Med (Lausanne). 2022; 9:991785.
PMID: 36186777
PMC: 9520336.
DOI: 10.3389/fmed.2022.991785.
Single-cell chromatin profiling of the primitive gut tube reveals regulatory dynamics underlying lineage fate decisions.
Smith R, Zhang H, Hu S, Yung T, Francis R, Lee L
Nat Commun. 2022; 13(1):2965.
PMID: 35618699
PMC: 9135761.
DOI: 10.1038/s41467-022-30624-w.
Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression.
Yu J, Yang K, Zheng J, Zhao P, Xia J, Sun X
Cell Death Dis. 2022; 13(4):388.
PMID: 35449124
PMC: 9023572.
DOI: 10.1038/s41419-022-04745-5.
Comprehensive clinicopathologic, molecular, and immunologic characterization of colorectal carcinomas with loss of three intestinal markers, CDX2, SATB2, and KRT20.
Lee J, Seo M, Yoo S, Cho N, Kwak Y, Lee K
Virchows Arch. 2022; 480(3):543-555.
PMID: 35029777
DOI: 10.1007/s00428-021-03260-w.
A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma.
Azcue P, Guerrero Setas D, Encio I, Ibanez-Beroiz B, Mercado M, Vera R
Cancers (Basel). 2021; 13(23).
PMID: 34885019
PMC: 8656725.
DOI: 10.3390/cancers13235909.